Raffles Medical Group Ltd (RAFLF)
OTCMKTS
· Delayed Price · Currency is USD
0.6000
-0.0671 (-10.06%)
At close: Jan 16, 2025
Raffles Medical Group Revenue
In the year 2024, Raffles Medical Group had annual revenue of 752.41M SGD with 6.27% growth. Raffles Medical Group had revenue of 386.72M in the half year ending December 31, 2024, a decrease of -6.86%.
Revenue
752.41M SGD
Revenue Growth
+6.27%
P/S Ratio
2.58
Revenue / Employee
251.73K SGD
Employees
2,989
Market Cap
1.42B USD
Revenue Chart
* This company reports financials in SGD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 752.41M | 44.37M | 6.27% |
Dec 31, 2023 | 708.04M | -116.91M | -14.17% |
Dec 31, 2022 | 824.95M | 99.72M | 13.75% |
Dec 31, 2021 | 725.23M | 157.03M | 27.64% |
Dec 31, 2020 | 568.20M | 46.17M | 8.84% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Raffles Medical Group News
- 2 months ago - Raffles Medical Group: China business still grew in 2024 - CNBC